Chameleon Biosciences

626 Bancroft Way Ste A


Developer of a gene delivery technology designed to overcome existing treatment barriers in gene therapy. The company’s technology shields the capsid from antibodies, reduces antibody production, and masks foreign proteins to increase tolerance, enabling patients to have access to treatments for an increased number of diseases.